Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.
about
Possibilities and challenges for developing a successful vaccine for leishmaniasisLocal suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasisIn vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisPlasma levels of interlukin-4 and Interferon-γ in patients with chronic or healed cutaneous leishmaniasis.CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.High-throughput analysis of synthetic peptides for the immunodiagnosis of canine visceral leishmaniasisIdentification of leishmania isolates from healing and nonhealing cutaneous leishmaniasis patients using internal transcribed spacer region PCR.NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous LeishmaniasisChildhood cutaneous leishmaniasis: report of 117 cases from Iran.Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis.PCR and microscopic identification of isolated Leishmania tropica from clinical samples of cutaneous leishmaniasis in human population of Kohat region in Khyber Pakhtunkhwa.Immunological perspectives of leishmaniasis.Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.Immune responses during cutaneous and visceral leishmaniasis.Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.Comparison of pro-inflammatory cytokines of non-healing and healing cutaneous leishmaniasis.Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide ImmunomodulationInterleukin-2 expression in lupoid and usual types of old world cutaneous leishmaniasisEndemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis.Serotonin transporter protein overexpression and association to Th17 and T regulatory cells in lupoid leishmaniasis.The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.Mercury enhances susceptibility to murine leishmaniasis.Cytokine Gene Expression in Healing and Non-Healing Cases of Cutaneous Leishmaniasis in Response to In vitro Stimulation with Recombinant gp63 Using Semi-Quantitative RT-PCR
P2860
Q26749758-BF621A83-69FA-4C0B-8AC3-B5ED77163B29Q28475723-42676CA5-1DE2-4CE3-BC0A-15F4558CB300Q33559668-9C79B931-7323-4572-9FB6-E1426B2699D9Q33593328-DE5524EC-DD1A-4BAF-BC5F-36BE596C094BQ33725704-DC0A4893-D76A-4F85-8178-FCF77DA440DCQ33942376-6A26AAF5-6477-4CC0-AD26-E55E58059551Q34024133-48905A1F-0F41-4FED-87CF-EF1E48BCA3EDQ34068560-7463D98F-70A0-48C6-95A0-796F053C765BQ34513470-9D1C7D08-43B3-4006-BC2A-EF658CAB5D42Q35786380-FD801106-CCEC-431F-981F-7E9D517FA6DBQ35845737-B292E7E0-1F6A-471B-9A84-E1445D50C4D4Q35884239-7E06CBA8-4730-4DD2-A4AF-4230D9392DBDQ35968320-3780324A-A37C-4A59-8CF2-496F36D9561CQ36028999-2BDC2690-8E3F-4D0B-9EEF-86CE7E3DDD9CQ36080146-2C2B28E8-CFF7-42BA-AE65-570931D3CE05Q36311439-C628D4E6-512F-4245-9BFD-3119F6B83FA7Q36370603-E4C747FA-FC49-4075-A509-949C0DE3FCB5Q36919427-2D320E7F-8DDB-4598-B99C-0217F2B9B8D7Q37435299-F2680160-D004-4AA7-8EB6-234A046E2738Q37706088-AFD180D6-2C2A-4CCB-ADFC-E125CCE1A0D1Q37770420-8B4BD3B2-4AF2-4031-9A10-1C4DAF917829Q37773297-7C35F7D6-AF56-4B7C-8E19-2ABBE79DD42FQ38235268-0D255C5B-C029-448A-A97F-622007FC035AQ38533597-17F1D2A0-CF6A-437F-9251-56331849AE62Q40239822-83A19577-C9ED-4840-A5FD-A4C171DC781BQ40342181-4D954DE4-030A-4418-9FCC-C33502D2849BQ40354630-4FF97A1C-2FC2-4F7F-87E8-0454E5E544DDQ41825082-FC227679-4CFE-46C9-AE92-D7E9F23AF963Q42180865-1F0F30EF-E0C0-4332-8887-C799515A7FA0Q43973081-0856CD0D-14A0-463A-B3AC-C9B505DF5BE2Q44104220-A52A35EF-E03C-476C-AC9B-CE3F2C145502Q46099419-B3107952-EEC9-48DE-ACDF-38C2BE0AC7ABQ53986328-16C04AB5-C631-4F6B-BA8F-0EBD012E9C0BQ58485935-98050C67-7B3C-4C65-B1A1-EEBF2E9C9038
P2860
Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparison of the immune profi ...... have recovered from infection.
@ast
Comparison of the immune profi ...... have recovered from infection.
@en
Comparison of the immune profi ...... have recovered from infection.
@nl
type
label
Comparison of the immune profi ...... have recovered from infection.
@ast
Comparison of the immune profi ...... have recovered from infection.
@en
Comparison of the immune profi ...... have recovered from infection.
@nl
prefLabel
Comparison of the immune profi ...... have recovered from infection.
@ast
Comparison of the immune profi ...... have recovered from infection.
@en
Comparison of the immune profi ...... have recovered from infection.
@nl
P2093
P2860
P1476
Comparison of the immune profi ...... have recovered from infection.
@en
P2093
A Kharazmi
M B Eslami
M H Alimohammadian
P2860
P304
P356
10.1128/IAI.68.4.1760-1764.2000
P407
P577
2000-04-01T00:00:00Z